EcoDrugPlus

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSBGRG00000019883
Gene Symbol: CYP46A1
1 Cross references
260 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSBGRG00000013200
Gene Symbol: DGAT1
1 Cross references
262 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSBGRG00000020593
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSBGRG00000005648
Gene Symbol: DPYD
1 Cross references
228 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSBGRG00000016318
Gene Symbol: DPP4
1 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSBGRG00000002518
Gene Symbol: DDR2
1 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSBGRG00000011292
Gene Symbol: DRD1
1 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSBGRG00000006710
Gene Symbol: DRD2
1 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSBGRG00000001826
Gene Symbol: DRD3
1 Cross references
209 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSBGRG00000009702
Gene Symbol: DRD5
1 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSBGRG00000013089
Gene Symbol: ENPP2
1 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSBGRG00000018605
Gene Symbol: EGLN1
1 Cross references
239 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).